Cardiovascular Research Centre, School of Medical Sciences, Örebro University Södra Grev, Rosengatan 32, 703 62, Örebro, Sweden.
Department of Infectious Diseases, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
J Mol Med (Berl). 2023 Dec;101(12):1615-1626. doi: 10.1007/s00109-023-02379-4. Epub 2023 Oct 20.
Defective LDL-C clearance and hence its elevation in the circulation is an established risk factor for cardiovascular diseases (CVDs) such as myocardial infarction (MI). A soluble LDL-receptor (sLDL-R) has been detected in human plasma which correlates strongly with circulating LDL-C and classical conditions that promote chronic inflammation. However, the mechanistic interplay between sLDL-R, inflammation, and CVDs remains to be investigated. Here, we report that stimulation of HepG2 cells with TNF-α induces the release of sLDL-R into culture supernatants. In addition, TNF-α induces gene expression of peptidases ADAM-17 and MMP-14 in HepG2 cells, and inhibiting these peptidases using TMI 1 significantly reduces the TNF-α induced sLDL-R release. We found that a soluble form of recombinant LDL-R (100 nM) can strongly bind to LDL-C and form a stable complex (KD = E-12). Moreover, incubation of HepG2 cells with this recombinant LDL-R resulted in reduced LDL-C uptake in a dose-dependent manner. In a nested case-control study, we found that baseline sLDL-R in plasma is positively correlated with plasma total cholesterol level. Furthermore, a twofold increase in plasma sLDL-R was associated with a 55% increase in the risk of future MI [AOR = 1.55 (95% CI = 1.10-2.18)]. Nevertheless, mediation analyses revealed that a significant proportion of the association is mediated by elevation in plasma cholesterol level (indirect effect β = 0.21 (95% CI = 0.07-0.38). Collectively, our study shows that sLDL-R is induced by a pro-inflammatory cytokine TNF-α via membrane shedding. Furthermore, an increase in sLDL-R could inhibit hepatic clearance of LDL-C increasing its half-life in the circulation and contributing to the pathogenesis of MI. KEY MESSAGES: TNF-α causes shedding of hepatocytic LDL-R through induction of ADAM-17 and MMP-14. sLDL-R binds strongly to LDL-C and inhibits its uptake by hepatocytic cells. Plasma sLDL-R is positively correlated with TNF-α and cholesterol. Plasma sLDL-R is an independent predictor of myocardial infarction (MI). Plasma cholesterol mediates the association between sLDL-R and MI.
LDL-C 清除缺陷导致其在循环中升高是心血管疾病(CVDs)如心肌梗死(MI)的既定风险因素。在人类血浆中已经检测到一种可溶性 LDL 受体(sLDL-R),它与循环 LDL-C 以及促进慢性炎症的经典条件密切相关。然而,sLDL-R、炎症和 CVDs 之间的机制相互作用仍有待研究。在这里,我们报告 TNF-α刺激 HepG2 细胞会诱导 sLDL-R 释放到培养上清液中。此外,TNF-α诱导 HepG2 细胞中肽酶 ADAM-17 和 MMP-14 的基因表达,并且使用 TMI 1 抑制这些肽酶可显著减少 TNF-α诱导的 sLDL-R 释放。我们发现,可溶性形式的重组 LDL-R(100 nM)可以强烈结合 LDL-C 并形成稳定的复合物(KD = E-12)。此外,重组 LDL-R 孵育 HepG2 细胞可导致 LDL-C 摄取呈剂量依赖性降低。在巢式病例对照研究中,我们发现血浆中 sLDL-R 的基线水平与血浆总胆固醇水平呈正相关。此外,血浆 sLDL-R 增加两倍与未来 MI 风险增加 55%相关 [AOR = 1.55(95%CI = 1.10-2.18)]。然而,中介分析显示,这种关联的很大一部分是由血浆胆固醇水平升高介导的(间接效应β= 0.21(95%CI = 0.07-0.38)。总之,我们的研究表明,sLDL-R 是由促炎细胞因子 TNF-α通过膜脱落诱导的。此外,sLDL-R 的增加可能会抑制肝脏对 LDL-C 的清除,从而增加其在循环中的半衰期,并导致 MI 的发病机制。主要发现:TNF-α通过诱导 ADAM-17 和 MMP-14 导致肝细胞 LDL-R 脱落。sLDL-R 与 LDL-C 强烈结合,并抑制肝细胞摄取 LDL-C。血浆 sLDL-R 与 TNF-α和胆固醇呈正相关。血浆 sLDL-R 是心肌梗死(MI)的独立预测因子。血浆胆固醇介导 sLDL-R 与 MI 之间的关联。